Idenix Pharmaceuticals Highlights Progress in Three HCV Programs

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, Monday announced significant progress in three HCV programs.
Fox Business